GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Morphic Holding Inc (STU:31Y) » Definitions » Credit Losses Provision

Morphic Holding (STU:31Y) Credit Losses Provision


View and export this data going back to 2019. Start your Free Trial

What is Morphic Holding Credit Losses Provision?

Credit Losses Provision only applies to banks.


Morphic Holding (STU:31Y) Business Description

Traded in Other Exchanges
Address
35 Gatehouse Drive, A2, Waltham, MA, USA, 02451
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.